As pharmaceutical manufacturers continue to advance their digital transformation strategies, a fundamental industry question remains: What capabilities must be in place to successfully deliver Pharma 4.0™?
In an era where agility, data-driven decision-making, and digital connectivity define manufacturing excellence, the Pharma 4.0™ in Action track at the 2026 ISPE Europe Annual Conference stands out as a must-attend content area for professionals seeking...
The 2025 ISPE D/A/CH workshop on “Pharma’s Journey to Digital Manufacturing and Supply” united pharma leaders, technology experts, and regulatory authorities for three days of intense exchange on the digital transformation of our industry.
This article summarizes the key findings from the 7th Pharma 4.0™ Survey, conducted in 2023. It explores the demographics of the survey respondents, maturity levels of Pharma 4.0™ adoption, enabling technologies being leveraged, anticipated benefits, and challenges encountered.
The field of advanced therapeutic medicinal products (ATMPs) has witnessed remarkable advancements in recent years. The Emerging Leaders (EL) community from the Belgium and Germany/Austria/Switzerland (D/A/CH) affiliates collaborated to develop an inclusive series of online seminars on ATMPs. This article gives highlights of the speakers, topics, and knowledge shared in ATMP online seminars...
